GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Sloan Ratio %

Invitro International (Invitro International) Sloan Ratio % : 0.00% (As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Invitro International's Sloan Ratio for the quarter that ended in Jun. 2097 was 0.00%.

As of Jun. 2097, Invitro International has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Invitro International Sloan Ratio % Historical Data

The historical data trend for Invitro International's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Sloan Ratio % Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Sloan Ratio %
Get a 7-Day Free Trial -162.50 1.85 12.31 -31.25 -41.67

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Invitro International's Sloan Ratio %

For the Diagnostics & Research subindustry, Invitro International's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitro International's Sloan Ratio % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Invitro International's Sloan Ratio % falls into.



Invitro International Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Invitro International's Sloan Ratio for the fiscal year that ended in Sep. 2096 is calculated as

Sloan Ratio=(Net Income (A: Sep. 2096 )-Cash Flow from Operations (A: Sep. 2096 )
-Cash Flow from Investing (A: Sep. 2096 ))/Total Assets (A: Sep. 2096 )
=(-1.9--1.8
-0.9)/2.4
=-41.67%

Invitro International's Sloan Ratio for the quarter that ended in Jun. 2097 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jun. 2097 )
=(-1.663--0.545
-0)/1.151
=-97.13%

Invitro International's Net Income for the trailing twelve months (TTM) ended in Jun. 2097 was -0.57 (Sep. 2096 ) + -0.5 (Dec. 2096 ) + -0.395 (Mar. 2097 ) + -0.198 (Jun. 2097 ) = $-1.66 Mil.
Invitro International's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2097 was -0.545 (Sep. 2096 ) + 0 (Dec. 2096 ) + 0 (Mar. 2097 ) + 0 (Jun. 2097 ) = $-0.55 Mil.
Invitro International's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2097 was 0 (Sep. 2096 ) + 0 (Dec. 2096 ) + 0 (Mar. 2097 ) + 0 (Jun. 2097 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invitro International  (OTCPK:IVRO) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jun. 2097, Invitro International has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Invitro International Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Invitro International's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitro International (Invitro International) Business Description

Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.